The European Food Safety Authority (EFSA) has launched an open consultation on the draft scientific opinion on the safety of caffeine that was presented recently to EFSA. The provisional findings of the Draft Scientific Opinion on the ...
Tags: energy drink, public health, Agriculture
Eisai has introduced the insomnia drug, Lunesta (eszopiclone), in Japan. Discovered and developed by Sunovion Pharmaceuticals, Lunesta is a non-benzodiazepine type GABAA agonist (non-benzodiazepine sedative hypnotic). In a Phase II/III ...